Biohealth Innovation
High-income countries are grappling with the challenge of caring for aging populations, many of whose members have chronic illnesses and declining capacity to manage activities of daily living. The 2017 Commonwealth Fund International Health Policy Survey of Older Adults in eleven countries showed that US seniors were sicker than their counterparts in other countries and, despite universal coverage under Medicare, faced more financial barriers to health care.
When: Tuesday, December 5, 2017 6:30 p.m. – 8:30 p.m. EST
Where: All Set Restaurant & Bar 8630 Fenton St. Silver Spring, MD 20910
It’s that time of the year again! Please join Capital Region chapter of Women In Bio as we celebrate the conclusion of an amazing 2017 at All Set Restaurant & Bar in Silver Spring, MD. Come mix & mingle with friends old and new over drinks and hors d’oeuvres, learn about the opportunities and resources that you have access to as WIB members, and participate in our raffle to win exciting prices!
Funding and Research Opportunities
The following funding opportunity announcements from the NHLBI or other components of the National Institutes of Health, might be of interest:
Maryland Tech Council announced today that Nora D. Volkow, M.D., Director of the National Institute on Drug Abuse, National Institutes of Health (NIH) will kick off its new Innovation Speaker Series. Dr. Volkow will discuss the current state of the opioid crisis nationally and locally. Additionally, her presentation will cover what research has shown about this particular addiction, its prevention and treatment, and how science may help end the massive public health crisis. Key industry leaders are expected to attend this inaugural series event, which will take place Wednesday, November 29, 2017 at the Universities at Shady Grove from 7:30-9:30 a.m.
The Johns Hopkins University and Deerfield Management announced today the creation of Bluefield Innovations, a collaboration designed to catalyze the development of early stage therapeutics. Funded by Deerfield, an investment management firm committed to advancing health care, Bluefield Innovations will provide up to $65 million in initial funding over five years to support the commercialization of early stage therapeutic research at Johns Hopkins, with additional funding available to advance research that shows strong commercial potential.
Bioterrorism threats and infectious disease outbreaks are on the rise. Emergent BioSolutions Inc. (EBS) has a stream of revenues from FDA-approved drugs, as well as a full pipeline of drugs under development, to combat these health threats.
QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today launched enhancements in its QIAGEN Clinical Insight (QCI) bioinformatics software automating the AMP/ASCO/CAP Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer, advancing precision medicine with the first solution to offer molecular pathologists critical information needed to guide oncologists' treatment decisions.
FDA approval based on Phase III program demonstrating up to 51% reduction in asthma exacerbations, significant improvement in lung function and a 75% reduction in daily oral steroid use
Date and time: Tuesday, 21 November 5:00PM - 8:00PM EST
Location: MedImmune 1 Medimmune Way Gaithersburg, MD 20878 United States
HBA Mid-Atlantic presents a panel of successful diverse women from the public and private healthcare sectors to share their experiences on harnessing one's power.
Scientists for the first time have tried editing a gene inside the body in a bold attempt to permanently change a person’s DNA to cure a disease.
David Narrow said the life of an entrepreneur is fast-paced and at times very stressful, but he has never loved any job more.
His medical technology firm, Sonavex, recently raised $3 million and took up new office space in Canton. The company is currently working on commercializing its product, which uses ultrasound technology to detect potentially harmful, post-surgical blood clots.
Date: Thursday, November 30, 2017
Location: Inova Center for Personalized Health3225 Gallows Road, Fairfax, VA 22031
Technology innovation continues to accelerate at an exponential rate, constantly outpacing the status quo and redefining limitations. Personal healthcare stands to benefit from these newfound opportunities.
Happiness changes over the course of your life.
There is "scientific evidence that people get happier as they get older," according to a Bank of America Merrill Lynch report that analyzed Nielsen data. "While there are differing theories as to why this is, most agree that it is an acceptance of aging that promotes contentedness."
It just wouldn’t feel like a Friday without some Trump cabinet intrigue so with that in mind, Alex Azar, the former president of Lilly’s U.S. business, has been tipped to be the next Secretary of Health and Human Services, according to Bloomberg. If he’s approved, Azar would succeed Tom Price, who resigned from the post amidst fallout over the cost of his extensive use of government travel via military and private jets.
AstraZeneca and its Maryland-based biologics research and development arm, MedImmune, announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has adopted a positive opinion, recommending benralizumab as an add-on maintenance treatment in adult patients with a type of severe asthma.
University System of Maryland (USM) Chancellor Robert L. Caret was elected chair today of the Association of Public and Land-grant Universities (APLU) Board of Directors. He succeeds University of Virginia President Teresa A. Sullivan.
Inova Health System's venture capital arm has been busy over the last year.
Since starting Inova Strategic Investments, Inova has closed three new direct company investments and two fund investments.
For the first time, the Food and Drug Administration has approved a digital pill — a medication embedded with a sensor that can tell doctors whether, and when, patients take their medicine.
The University of Maryland was honored for its contributions to the economic development of the community at the 2017 Innovation & Economic Prosperity (IEP) University Awards by the Association of Public and Land-grant Universities (APLU). As winner of the Economic Engagement Connections Award, IEP’s top prize, and the Place Award. UMD is the first two-time winner of the Connections Award, and the first institution to garner both a category award and the Connections Award in the same year. The award winners were announced at the the 2017 APLU Annual Meeting on Nov. 12, 2017.
A wave of disappointing third-quarter results and clinical trial failures by the largest biotechs in late October 2017 signaled to some the start of another market swoon, akin to the one that dented share prices starting in late 2015 through 2016.
The Association of University Research Parks (AURP) announces the University of Maryland’s Discovery District as the host for the AURP annual International Conference, to be held in College Park, Md., October 22- 26, 2018.
Billionaire Microsoft co-founder Bill Gates is to invest $50 million in the Dementia Discovery Fund, a venture capital fund that brings together industry and government to seek treatments for the brain-wasting disease.
It is hard for most us to imagine what life in the shadow of the Berlin Wall was like for citizens of Soviet-controlled East Berlin and NATO-aligned West Berlin. It divided not just a city, but families, communities, and, indeed, a whole nation. Although the wall completely encircled the democratic and free city of West Berlin, for the unlucky citizens of East Berlin it was a prison – complete with guard towers, anti-vehicle trenches and fakir beds lining its notorious “death strip.”
United Therapeutics is set to take a big step forward in its plans to pursue advances in the field of organ transplantation thanks to a new partnership with the University of Maryland. The company has announced a $24 million research partnership that will help the school establish a center specializing in cardiac xenotransplantation research, the first of its kind in the US.
Partners HealthCare System has raised has raised $171 million for a second innovation fund targeting seed stage investments in life science startups, according to a news release. The Brigham and Women’s Hospital and Massachusetts General Hospital each committed $50 million for the fund.
The University of Maryland dedicates the new A. James Clark Hall today, a 184,000-square-foot facility that will catalyze engineering innovation and bioengineering breakthroughs and serve as a hub for new partnerships and collaborations throughout the Baltimore-Washington region. A. James Clark Hall is the only space in the nation dedicated to bioengineering and the translation of health-related products that incorporates FDA-funded Centers of Excellence in both Regulatory Science and Pediatric Device Innovation.
M-1 Ventures Demo Day is an event for partners, investors, industry leaders and the press to learn about market-changing technologies and solutions from each of the graduating M-1 startups and get a preview of where each company is headed next.
Johns Hopkins University has unveiled the 2017-2018 cohort of 10 mainly US-based startups to take part in its Social Innovation Lab incubator for non-profit businesses.
Every year, nearly 50,000 research proposals are submitted to the only federal agency in the United States that funds discovery research in all fields of science and engineering: the National Science Foundation (NSF). The agency uses merit review to pick proposals that show the greatest potential to fulfill NSF’s mission to promote the progress of science and serve the national interest.
Recent developments in bioengineering promise the possibility of new diagnostic and treatment strategies, novel industrial processes, and innovative approaches to thorny problems in fields such as nutrition, agriculture, and biomanufacturing. As modern genetics has matured and developed technologies of increasing power, debates over risk assessments and proper applications of the technology, and over who should have decision-making power over such issues, have become more prominent. Recently, some scientists have advocated that ethicists “step out of the way,” whereas others have called for greater ethical scrutiny, or even for moratoria on some lines of research.
Wednesday November 15, 2017 5:00 PM - 7:00 PM
TEDCO IPO Conference Room 7021 Columbia Gateway Suite 200 Columbia, MD 21046
Does your Startup need Funding & Mentorship?
Launch your startup with the FounderTrac Startup Accelerator, a partnership between the MTC, LAUNCH! Annapolis, MCVC Partners and TEDCO.
You can raise capital, learn from a proven curriculum and receive hands-on mentoring from successful entrepreneurs and top executives to scale your company.
The Texas Medical Center, the largest medical complex in the world, today announced the TMC Venture Fund, a $25 million initiative designed to support technologies and early-stage companies to flourish in Houston’s health care ecosystem and further the TMC’s mission to advance health, education and research.
William Osler, often called the father of modern medicine, famously advised his students: “Just listen to your patient; he is telling you the diagnosis.” A century later, clinicians and health system leaders started tuning out the patient’s voice, turning instead to electronic health records and the latest care protocols to manage their most complicated and high-need patients. We believe it’s time for an urgent and strategic reset. The factors that lead people to become our nation’s costliest are complex. But they call for, at the start, the simplest intervention: listening.
Eli Lilly and Company is an innovation-driven biopharmaceutical company that aspires to make a significant contribution to humanity by improving global health in the 21st century. In this article, part of our Biopharma Frontiers series on how the pharmaceutical industry is evolving and how leaders can adapt, David A. Ricks, the chairman and CEO of Eli Lilly, discusses the opportunities and rewards for innovation and the implications for industry business models. This article is an edited summary of his conversation with McKinsey.
Earlier this year the US Food and Drug Administration (FDA) heralded the forthcoming launch of its pre-certification pilot program for new digital health software which it hopes will help revolutionise the regulation of digital healthcare solutions in the US and allow innovations to safely reach the global market in a timely way, to the benefit of end users.